How to add a private blood testing service to a UK telehealth clinic in 2026: phlebotomy, labs, and acting on results

Private blood testing looks like a simple product: take blood, run it, show a number. It is not. The test is the easy part; the hard, regulated part is what happens to the result — who interprets it, how an abnormal finding reaches the patient safely, and what duty of care attaches the moment you hand someone a lab report. Done well it is a strong add-on for a telehealth clinic. Done as a numbers-only service, it is a liability. Here is how to add it properly.

Why blood testing complements telehealth

Testing underpins a lot of remote care — thyroid, gout, general health checks, monitoring for medicines — so a clinic that already prescribes has natural reasons to offer it, either standalone or bundled with a condition service. Demand for private health checks is real, and testing deepens the clinical relationship.

But blood testing is a clinical service with a clinical duty, not a retail product. The moment you provide a result you take on responsibility for it being accurate, understood and acted on. Building it as though the number is the deliverable is the fundamental error.

Sample collection: kits vs phlebotomy

There are two collection routes, and they suit different tests. Home finger-prick kits are convenient and fine for many analytes, but sample quality is patient-dependent and some tests need a venous sample. Phlebotomy — a trained professional drawing venous blood, at a clinic or via a mobile service — gives better samples and covers more tests, at higher cost and lower convenience.

Either way, sample integrity governs result validity: correct tubes, labelling, storage and timely transport to the lab, with some samples time- or temperature-sensitive. A mishandled sample produces a wrong number, and a wrong number acted on is a patient-safety issue, not an inconvenience.

Choosing an accredited laboratory

Analysis must go to a properly accredited laboratory. In the UK that means UKAS accreditation (to ISO 15189 for medical labs), which is the assurance that results are analytically reliable. This is not a corner to cut — the credibility of the whole service rests on the lab.

Your relationship with the lab also shapes turnaround, the test menu, reference ranges and how results are returned, all of which affect the patient experience and your ability to act promptly. Treat lab selection as a core clinical-governance decision, not procurement.

Interpreting and acting on results

Here is the part operators underestimate: a result needs a clinician to interpret it and decide what happens next. A number against a reference range is not care. Someone has to judge whether it is normal, borderline or concerning in the context of that patient, and communicate it appropriately.

That means a defined process for normal results, for abnormal ones that need action, and — critically — for serious findings that need urgent contact and onward referral. A markedly abnormal result sitting in an unread queue is exactly the failure that turns a blood-test service into a serious incident. Tie this to your safeguarding and out-of-hours processes.

The regulatory and governance picture

Several duties converge. Providing and acting on diagnostic tests can be a regulated activity bringing CQC into scope — confirm your position rather than assuming. Results are special-category health data under UK GDPR, so consent, security and retention all apply. And clinical governance must cover the whole chain: collection, lab, interpretation, communication and follow-up.

Get the CQC question answered before launch; our guide to CQC registration covers who needs to register. And handle the data properly — see UK GDPR for telehealth. Governance here is the service, not paperwork around it.

A markedly abnormal result sitting in an unread queue is exactly the failure that turns a blood-test service into a serious incident. The moment you hand someone a lab report, a duty of care attaches — design for it.

Building the service

Operationally the service is a chain, and it is only as strong as its weakest link: collection, transport, accredited analysis, clinician interpretation, safe communication, and follow-up. Each needs defined procedures, and the interpretation-and-communication end needs real clinical capacity — the bit that is tempting to under-resource and dangerous to skimp on. Our clinical SOPs guide covers making the chain consistent.

As with any regulated add-on, the build-versus-partner question turns on the accredited, governed infrastructure — the lab relationship, the result-handling workflow — rather than the front-end booking.

How PExpo supports a clinic adding testing

PExpo provides the regulated layer and patient record that a testing service depends on — governed workflows, result handling tied to the clinical record, and the compliance footing — so a clinic can add blood testing as a defined, safe service rather than stitching together a kit, a lab and a spreadsheet.

You run the clinical relationship and interpretation; the governed infrastructure sits underneath. See our clinic model for the scope, or pricing for the commercials.

Private blood testing rewards clinics that build the whole chain — safe collection, a UKAS-accredited lab, clinician interpretation, and a reliable route for acting on abnormal results — rather than selling numbers. Settle the CQC and data-protection positions first. See our guides to CQC registration and UK GDPR for telehealth, or our clinic model.

Frequently asked questions